Many cannabis stocks could be in danger. First a
Post# of 126925
(Total Views: 170)
Posted On: 12/11/2017 8:18:55 AM
Many cannabis stocks could be in danger. First a comparison, in 2006/07/08 stevia, a sugar replacement was a much invested topic. It was legal in China, but not the western world. Well, legality was postponed until 2009, which gave big companies like Cargil time to get huge stevia plantation growing in China. One of the most popular stocks SUWN had in big run in 2006, but never went higher.
Now fast forward 10 years to today, big pharma is scrambling to get laws to help them corner the market on medical used of cannabis .Yes, some of the small pot stocks could do well, but none of the small stevia stocks did, I am not saying get out, just be wary and set stops. Stocks poster here, TRTC and ETST look good to me technically.
Story>>>>>
Big Pharma Tries to Monopolize CBD Oil Market
https://articles.mercola.com/sites/articles/a...=148052291
Story at-a-glance
The cannabinoids in cannabis — cannabidiol (CBD) and tetrahydrocannabinol (THC) — work by way of naturally-occurring cannabinoid receptors embedded in cell membranes throughout your body
The fact that your body is replete with cannabinoid receptors, key to so many biological functions, is why there's such enormous medical potential for cannabis
South Dakota has rescheduled CBD from a Schedule I to a Schedule IV substance by excluding it from the definition of marijuana
GW Pharmaceuticals failed in its efforts to restrict Schedule IV classification to FDA approved CBD products only, which prevented the company from creating a monopoly in South Dakota
The legal status of CBD oil as a nutritional supplement is now threatened by drug companies seeking FDA approval for CBD-containing drugs
Now fast forward 10 years to today, big pharma is scrambling to get laws to help them corner the market on medical used of cannabis .Yes, some of the small pot stocks could do well, but none of the small stevia stocks did, I am not saying get out, just be wary and set stops. Stocks poster here, TRTC and ETST look good to me technically.
Story>>>>>
Big Pharma Tries to Monopolize CBD Oil Market
https://articles.mercola.com/sites/articles/a...=148052291
Story at-a-glance
The cannabinoids in cannabis — cannabidiol (CBD) and tetrahydrocannabinol (THC) — work by way of naturally-occurring cannabinoid receptors embedded in cell membranes throughout your body
The fact that your body is replete with cannabinoid receptors, key to so many biological functions, is why there's such enormous medical potential for cannabis
South Dakota has rescheduled CBD from a Schedule I to a Schedule IV substance by excluding it from the definition of marijuana
GW Pharmaceuticals failed in its efforts to restrict Schedule IV classification to FDA approved CBD products only, which prevented the company from creating a monopoly in South Dakota
The legal status of CBD oil as a nutritional supplement is now threatened by drug companies seeking FDA approval for CBD-containing drugs
(0)
(0)